Class information for:
Level 1: ADAMS SUPER BRAIN STUDIES//LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS//ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
26458 254 46.7 90%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
209 3       GHRELIN//ADRENOMEDULLIN//NEUROPEPTIDE Y 51926
2027 2             PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP 5415
26458 1                   ADAMS SUPER BRAIN STUDIES//LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS//ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN 254

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ADAMS SUPER BRAIN STUDIES address 2708901 10% 87% 26
2 LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS address 2120635 8% 84% 21
3 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN authKW 1619771 6% 84% 16
4 ADNP authKW 1465504 6% 76% 16
5 SECT DEV MOL PHARMACOL address 1460616 11% 45% 27
6 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN ADNP authKW 1309032 6% 78% 14
7 DAVUNETIDE authKW 885237 4% 82% 9
8 NAP DAVUNETIDE authKW 841525 3% 100% 7
9 NAP authKW 664499 13% 17% 33
10 CYTOSQUELETTE address 636812 6% 38% 14

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Neurosciences 2011 52% 0% 131
2 Biochemistry & Molecular Biology 360 33% 0% 85
3 Pharmacology & Pharmacy 214 19% 0% 48
4 Psychiatry 103 8% 0% 21
5 Endocrinology & Metabolism 37 6% 0% 15
6 Obstetrics & Gynecology 35 4% 0% 11
7 Developmental Biology 16 2% 0% 5
8 Clinical Neurology 10 4% 0% 11
9 Cell Biology 8 5% 0% 13
10 Behavioral Sciences 6 2% 0% 4

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ADAMS SUPER BRAIN STUDIES 2708901 10% 87% 26
2 LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS 2120635 8% 84% 21
3 SECT DEV MOL PHARMACOL 1460616 11% 45% 27
4 CYTOSQUELETTE 636812 6% 38% 14
5 U366 558416 5% 39% 12
6 DR DIANA ZELMAN ELTON ELBAUM MOL NEUROENDOC 500906 2% 83% 5
7 ELTON NEUROENDOCRINOL 500906 2% 83% 5
8 ELTON NEUROENDOCRINOL HUMAN MOL GENET 360653 1% 100% 3
9 ELTON NEUROENDOCRINOLSAGOL NEUROSCI 360653 1% 100% 3
10 SACKLER MEDADAMS SUPER BRAIN STUDIES 360653 1% 100% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF MOLECULAR NEUROSCIENCE 37264 11% 1% 29
2 NEUROBIOLOGY OF DISEASE 1174 2% 0% 6
3 PEPTIDES 1101 4% 0% 9
4 MOLECULAR PSYCHIATRY 839 2% 0% 4
5 JOURNAL OF NEUROCHEMISTRY 816 5% 0% 12
6 CNS DRUG REVIEWS 736 0% 1% 1
7 JOURNAL OF ALZHEIMERS DISEASE 657 2% 0% 5
8 NEURON GLIA BIOLOGY 621 0% 1% 1
9 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 557 4% 0% 10
10 CURRENT ALZHEIMER RESEARCH 505 1% 0% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN 1619771 6% 84% 16 Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN
2 ADNP 1465504 6% 76% 16 Search ADNP Search ADNP
3 ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN ADNP 1309032 6% 78% 14 Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN+ADNP Search ACTIVITY+DEPENDENT+NEUROPROTECTIVE+PROTEIN+ADNP
4 DAVUNETIDE 885237 4% 82% 9 Search DAVUNETIDE Search DAVUNETIDE
5 NAP DAVUNETIDE 841525 3% 100% 7 Search NAP+DAVUNETIDE Search NAP+DAVUNETIDE
6 NAP 664499 13% 17% 33 Search NAP Search NAP
7 ACTIVITY DEPENDENT NEUROTROPHIC FACTOR 453122 3% 54% 7 Search ACTIVITY+DEPENDENT+NEUROTROPHIC+FACTOR Search ACTIVITY+DEPENDENT+NEUROTROPHIC+FACTOR
8 ADNF 9 429346 2% 71% 5 Search ADNF+9 Search ADNF+9
9 STOP KO MICE 360653 1% 100% 3 Search STOP+KO+MICE Search STOP+KO+MICE
10 STOP PROTEIN 273217 2% 45% 5 Search STOP+PROTEIN Search STOP+PROTEIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 MAGEN, I , GOZES, I , (2014) DAVUNETIDE: PEPTIDE THERAPEUTIC IN NEUROLOGICAL DISORDERS.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 23. P. 2591 -2598 78 74% 6
2 GOZES, I , (2011) NAP (DAVUNETIDE) PROVIDES FUNCTIONAL AND STRUCTURAL NEUROPROTECTION.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 10. P. 1040-1044 45 82% 14
3 GOZES, I , (2011) MICROTUBULES (TAU) AS AN EMERGING THERAPEUTIC TARGET: NAP (DAVUNETIDE).CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 31. P. 3413-3417 43 83% 17
4 SHIRYAEV, N , PIKMAN, R , GILADI, E , GOZES, I , (2011) PROTECTION AGAINST TAUOPATHY BY THE DRUG CANDIDATES NAP (DAVUNETIDE) AND D-SAL: BIOCHEMICAL, CELLULAR AND BEHAVIORAL ASPECTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 25. P. 2603-2612 50 69% 11
5 GOZES, I , IRAM, T , MARYANOVSKY, E , ARVIV, C , ROZENBERG, L , SCHIRER, Y , GILADI, E , FURMAN-ASSAF, S , (2014) NOVEL TUBULIN AND TAU NEUROPROTECTIVE FRAGMENTS SHARING STRUCTURAL SIMILARITIES WITH THE DRUG CANDIDATE NAP (DAVUENTIDE).JOURNAL OF ALZHEIMERS DISEASE. VOL. 40. ISSUE . P. S23-S36 50 62% 6
6 GOZES, I , (2016) THE CYTOSKELETON AS A DRUG TARGET FOR NEUROPROTECTION: THE CASE OF THE AUTISM-MUTATED ADNP.BIOLOGICAL CHEMISTRY. VOL. 397. ISSUE 3. P. 177 -184 41 76% 0
7 GOZES, I , SRAGOVICH, S , SCHIRER, Y , IDAN-FELDMAN, A , (2016) D-SAL AND NAP: TWO PEPTIDES SHARING A SIP DOMAIN.JOURNAL OF MOLECULAR NEUROSCIENCE. VOL. 59. ISSUE 2. P. 220 -231 39 66% 1
8 MERENLENDER-WAGNER, A , SHEMER, Z , TOULOUMI, O , LAGOUDAKI, R , GILADI, E , ANDRIEUX, A , GRIGORIADIS, NC , GOZES, I , (2014) NEW HORIZONS IN SCHIZOPHRENIA TREATMENT: AUTOPHAGY PROTECTION IS COUPLED WITH BEHAVIORAL IMPROVEMENTS IN A MOUSE MODEL OF SCHIZOPHRENIA.AUTOPHAGY. VOL. 10. ISSUE 12. P. 2324 -2332 38 72% 2
9 GOZES, I , (2017) SEXUAL DIVERGENCE IN ACTIVITY-DEPENDENT NEUROPROTECTIVE PROTEIN IMPACTING AUTISM, SCHIZOPHRENIA, AND ALZHEIMER'S DISEASE.JOURNAL OF NEUROSCIENCE RESEARCH. VOL. 95. ISSUE 1-2. P. 652 -660 30 81% 0
10 GOZES, I , SCHIRER, Y , IDAN-FELDMAN, A , DAVID, M , FURMAN-ASSAF, S , (2014) NAP ALPHA-AMINOISOBUTYRIC ACID (ISONAP).JOURNAL OF MOLECULAR NEUROSCIENCE. VOL. 52. ISSUE 1. P. 1-9 26 79% 10

Classes with closest relation at Level 1


Rank Class id link
1 28746 HUMANIN//COLIVELIN//S14G HUMANIN
2 1356 PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP
3 19622 DISC1//DISRUPTED IN SCHIZOPHRENIA 1//FEZ1
4 5367 DETYROSINATION//GLUTAMYLATION//TUBULIN TYROSINE LIGASE
5 361 TAU//TAUOPATHY//PAIRED HELICAL FILAMENTS
6 121 FETAL ALCOHOL SYNDROME//FETAL ALCOHOL SPECTRUM DISORDERS//PRENATAL ALCOHOL EXPOSURE
7 22674 MANGANESE ENHANCED MRI//MEMRI//MANGANESE ENHANCED MRI MEMRI
8 9971 L1CAM//X LINKED HYDROCEPHALUS//L1
9 37080 7 8 DIHYDROXYFLAVONE//8 DIHYDROXYFLAVONE//TRKB AGONIST
10 25962 CEREBROLYSIN//CEREBROLYSIN R//QEEG SLOWING

Go to start page